Aurobindo Pharma Limited Share Price and Company Fundamentals

4.150 (0.784%)
52 week
503.45 - 981.4

Last traded: Yesterday at 9:59 AM

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, over the counter drugs, and dietary supplements, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

Key Metrics

PE ratio


PB ratio


Dividend yield




Market cap


Enterprise value


Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Mailing addressGalaxy, Plot No. 1 22nd-24th Floor Survey No.83/1, Hyderabad Knowledge City Raidurg Panmaktha, Ranga Reddy District Hyderabad 500032 India
Phone / Fax91 40 6672 5000 / 91 40 2374 1080


Dividend yield


Dividend amount


Payout ratio


5Y Avg. yield


Aurobindo Pharma Limited paid ₹9.00 dividend and the ex-dividend date was 06 June 2022.The dividend payout ratio is 9.96%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.AUROPHARMA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

AUROPHARMA's forward dividend amount is ₹9 and the forward dividend yield is 1.72%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Aurobindo Pharma Limited.

NameTitleAgeTotal Pay
Mr. Kambam Nithyananda ReddyVice Chairman & MD6323.3M
Dr. Meenakshi Sunderam SivakumaranWhole-Time Director7823.31M
Mr. Mettu Madan Mohan ReddyWhole-Time Director6152.34M
Mr. Penaka Sarath Chandra ReddyWhole-Time Director3614.6M
Mr. Santhanam SubramanianChief Financial Officer60
Mr. Sanjeev Indravadan DaniCOO & Head of Formulations61
Dr. S. Vijaya KumarPres of Technical55
Mr. Arvind BothraHead of Investor Relations & Corp. Communications
Mr. B. Adi ReddyCompliance Officer & Company Sec.
Mr. G. P. PrasadSr. VP of Global Fin. & Operations

Profitability and management effectiveness

Profit margin


Operating margin


Return on assets


Return on equity


Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Aurobindo Pharma Limited is and its enterprise value is .

The AUROPHARMA's stocks Beta value is 0.78 making it 22% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Aurobindo Pharma Limited (NSE:AUROPHARMA) Frequently Asked Questions

1. What is Aurobindo Pharma Limited's Stock Symbol?

Aurobindo Pharma Limited trades on NSE under the ticker symbol "AUROPHARMA".

2. What is Aurobindo Pharma Limited's stock price today?

One share of AUROPHARMA stock can currently be purchased for approximately ₹533.4.

3. How can I contact Aurobindo Pharma Limited?

Aurobindo Pharma Limited's mailing address is Galaxy, Plot No. 1 22nd-24th Floor Survey No.83/1, Hyderabad Knowledge City Raidurg Panmaktha, Ranga Reddy District Hyderabad 500032 India. The company can be reached via phone at 91 40 6672 5000.

4. What is Aurobindo Pharma Limited's official website?

The official website of Aurobindo Pharma Limited is